Aberdeen Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.7M Buy
172,438
+15,536
+10% +$1.42M 0.03% 480
2025
Q1
$17.6M Sell
156,902
-213,381
-58% -$24M 0.03% 424
2024
Q4
$39M Buy
370,283
+1,982
+0.5% +$209K 0.07% 244
2024
Q3
$39.6M Sell
368,301
-85,169
-19% -$9.16M 0.07% 250
2024
Q2
$49.2M Buy
453,470
+12,154
+3% +$1.32M 0.09% 206
2024
Q1
$58.2M Buy
441,316
+20,723
+5% +$2.74M 0.11% 189
2023
Q4
$51.2M Buy
420,593
+147,606
+54% +$18M 0.11% 200
2023
Q3
$30.6M Buy
272,987
+69,739
+34% +$7.83M 0.08% 230
2023
Q2
$29.6M Buy
203,248
+141,033
+227% +$20.5M 0.07% 266
2023
Q1
$8.04M Buy
62,215
+8,028
+15% +$1.04M 0.02% 506
2022
Q4
$6.91M Buy
54,187
+4,050
+8% +$516K 0.02% 508
2022
Q3
$5.24M Sell
50,137
-523
-1% -$54.7K 0.02% 545
2022
Q2
$5.38M Sell
50,660
-1,004
-2% -$107K 0.02% 535
2022
Q1
$6.69M Sell
51,664
-20,995
-29% -$2.72M 0.02% 527
2021
Q4
$8.96M Sell
72,659
-3,851
-5% -$475K 0.02% 512
2021
Q3
$11M Sell
76,510
-6,090
-7% -$875K 0.02% 475
2021
Q2
$12.9M Sell
82,600
-3,228
-4% -$504K 0.03% 447
2021
Q1
$13.3M Buy
85,828
+5,845
+7% +$908K 0.03% 435
2020
Q4
$12M Buy
79,983
+3,271
+4% +$489K 0.03% 426
2020
Q3
$10.1M Sell
76,712
-11,159
-13% -$1.48M 0.03% 428
2020
Q2
$10.2M Sell
87,871
-5,688
-6% -$659K 0.03% 412
2020
Q1
$9.19M Buy
93,559
+1,256
+1% +$123K 0.03% 402
2019
Q4
$13.4M Sell
92,303
-2,136
-2% -$310K 0.03% 401
2019
Q3
$12.6M Sell
94,439
-59,722
-39% -$7.96M 0.03% 402
2019
Q2
$17.6M Sell
154,161
-2,604
-2% -$298K 0.04% 383
2019
Q1
$19.4M Buy
156,765
+52,095
+50% +$6.46M 0.04% 364
2018
Q4
$10.3M Buy
104,670
+394
+0.4% +$38.9K 0.02% 441
2018
Q3
$13.3M Buy
104,276
+4,859
+5% +$620K 0.02% 451
2018
Q2
$10.8M Buy
99,417
+11,338
+13% +$1.23M 0.02% 465
2018
Q1
$9.32M Buy
88,079
+9,723
+12% +$1.03M 0.02% 459
2017
Q4
$9.18M Buy
78,356
+28,760
+58% +$3.37M 0.02% 465
2017
Q3
$5.64M Buy
+49,596
New +$5.64M 0.01% 530